TL;DR: BillionToOne is a Y Combinator Summer 2017 startup The genetic testing platform detecting and measuring disease., currently public with a team of 300.
The genetic testing platform detecting and measuring disease.
Last verified:
BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.
Built by LemStudio
Yes. BillionToOne was funded by Y Combinator in the Summer 2017 batch. The genetic testing platform detecting and measuring disease.
BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the onl…
BillionToOne was part of Y Combinator's Summer 2017 batch.
BillionToOne has a team of 300 people according to Y Combinator's directory.
BillionToOne is currently listed as Public with a team of 300 in Y Combinator's directory.
Loading interactive view…